Michael Ghadimi
Overview
Explore the profile of Michael Ghadimi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
163
Citations
2219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Johansen K, Augustinus S, Wellner U, Andersson B, Beane J, Bjornsson B, et al.
Surgery
. 2025 Mar;
:109272.
PMID: 40055078
No abstract available.
2.
Hendriks T, Augustinus S, Andersson B, Williamson C, Beane J, Davis C, et al.
Ann Surg
. 2025 Feb;
PMID: 39982716
Background: Composite outcome measures aim to provide a more holistic view when determining the effectiveness and safety of surgical interventions. Recently, 'Ideal Outcome' (IO) harmonized the European and American composite...
3.
Gaedcke J, Sahrhage M, Ebeling M, Azizian A, Ruhlmann F, Bernhardt M, et al.
Sci Rep
. 2025 Feb;
15(1):5401.
PMID: 39948076
Low anterior resection (LAR) and abdominoperineal resection (APR) are the two main surgical procedures after preoperative chemoradiotherapy (CRT) for locally advanced rectal cancer. APR is associated with poorer prognosis; however...
4.
Ghadimi M, Pelzer U, Besselink M, Siveke J, Telgmann R, Braren R, et al.
BMC Cancer
. 2025 Feb;
25(1):208.
PMID: 39915735
Background: Based on current guidelines, surgical treatment of hepatic oligometastases in patients with pancreatic ductal adenocarcinoma (PDAC) is not primarily recommended. Systematic chemotherapy is the therapy of choice for these...
5.
Ghadimi M, Kalff J, Keck T, Fischer S
Zentralbl Chir
. 2025 Feb;
150(1):26-27.
PMID: 39909056
No abstract available.
6.
Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, et al.
N Engl J Med
. 2025 Jan;
392(4):323-335.
PMID: 39842010
Background: The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy. Methods: In this phase 3,...
7.
Hampe L, Kuffer S, Niemeier T, Scheele N, Hampe L, Riedl A, et al.
Front Immunol
. 2025 Jan;
15:1509051.
PMID: 39763660
Background: Esophageal cancer has a poor prognosis despite treatment advancements. Although the benefit of neoadjuvant chemoradiotherapy (CRT) followed by adjuvant immunotherapy is evident, the effects of CRT on PD-L1 expression...
8.
Tschaidse T, Hofmann F, Renz B, Hungbauer M, Klinger C, Buhr H, et al.
BMC Surg
. 2025 Jan;
25(1):4.
PMID: 39755601
Background: Pancreatic ductal adenocarcinoma (PDAC) typically occurs in an older patient population. Yet, early-onset pancreatic cancer (EOPC) has one of the fastest growing incidence rates. This study investigated the influence...
9.
Kiessler M, Jager C, Reyes C, Pergolini I, Schorn S, Goss R, et al.
Langenbecks Arch Surg
. 2024 Dec;
410(1):14.
PMID: 39710775
Objective: Splenectomy is regularly performed in total and distal pancreatectomy due to technical reasons, lymph node dissection and radicality of the operation. However, the spleen serves as an important organ...
10.
Bosch F, Schild-Suhren S, Yilmaz E, Ghadimi M, Karampalis A, Borner N, et al.
Int J Med Inform
. 2024 Nov;
193:105684.
PMID: 39546949
Background: The assessment of clinical outcome quality, particularly in surgery, is crucial for healthcare improvement. Traditional cross-sectional analyses often fall short in timely and systematic identification of clinical quality issues....